The Traub Law Firm Expands Its Professional Services in Wrongful Death Claims to Pflugerville and Round Rock TX
Austin Accident Lawyer, Andrew Traub, expands legal practice of the Traub Law Firm to the…
Austin Accident Lawyer, Andrew Traub, expands legal practice of the Traub Law Firm to the…
The firm is looking to raise up to $360 million and is expected to trade…
Invested Mom – a financial education platform for mothers – announces a new syllabus for…
TOKYO, Mar 9, 2023 – (JCN Newswire) – Hitachi, Ltd. (TSE: 6501) today announced that…
Report also found Gen Z and Millennial Government Workers Twice as Likely to Have Poor…
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has issued a correction to the previously published Long-Term Issue Credit…
Both doses of BNC210 as an acute treatment resulted in reductions in anxiety across multiple…
Calgary, Alberta–(Newsfile Corp. – March 8, 2023) – Circa Enterprises Inc. (TSXV: CTO) (“Circa” or…
TOKYO, Mar 9, 2023 – (JCN Newswire) – Eisai Co., Ltd. announced today that it…
EVANSVILLE, Ind.–(BUSINESS WIRE)–Berry Global Group, Inc. (NYSE: BERY) (“Berry”), a leading supplier of packaging solutions…
BUENOS AIRES–(BUSINESS WIRE)–Loma Negra, (NYSE: LOMA; BYMA: LOMA), (“Loma Negra” or the “Company”), the leading…
ROCKVILLE, MD, March 08, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company…
Quoin announced dosing of first patient in double blinded clinical study to evaluate QRX003 for…
TORONTO, Ontario and CAMBRIDGE, Massachusetts, March 08, 2023 (GLOBE NEWSWIRE) — Completed all preclinical studies…
– Nirogacestat Treatment Significantly Improved Progression-Free Survival, Objective Response Rate and Key Patient Reported Outcomes…
NEWS RELEASE – REGULATED INFORMATIONMARCH 8, 2023, 5:00 pm ET/ 23:00 CET IRVINE, CA, and…
SEATTLE, March 08, 2023 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
NEW YORK & SINGAPORE & HONG KONG–(BUSINESS WIRE)–Dr. Calvin Choi, chairman of AMTD Group and…
TORONTO and CHICAGO, March 08, 2023 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals (TSX: MDP; TSX: MDP.DB; OTCQX: MEDXF) today…
Entered into a €40 million credit facility with the European Investment Bank and closed an…